Saturday 26 November 2022 10:08 PM Drug marked as 'beginning of the end for dementia' in doubt over brain bleed ... trends now
Breakthrough drug marked as 'beginning of the end for dementia' which ails a million Britons in doubt over brain bleed risks, expert warns
Breakthrough dementia drug Lecanemab was hailed as 'beginning of the end' But it's future cast in doubt over risk of brain bleeds Alzheimer's experts warned One in ten patients in the most recent lecanemab trial suffered brain swelling An one in six experienced brain bleeds which could hike the costs of the drug By Ethan Ennals For The Mail On Sunday
Published: 22:00 GMT, 26 November 2022 | Updated: 22:00 GMT, 26 November 2022
A breakthrough drug hailed as 'the beginning of the end for dementia' can trigger dangerous brain bleeds, a top Alzheimer's expert has warned.
Lecanemab, which has been trialed across America, was found to drastically slow the disease's progression. And last week, Professor John Hardy, a world-leading dementia researcher at University College London (UCL) – whose original research paved the way to creating lecanemab – made headlines when he said he hoped the drug would be available on the NHS in a year.
But speaking to The Mail on Sunday, he warned that prescribing lecanemab has risks which could dramatically hike its costs.
One in ten patients in the
read more from dailymail.....
Tags
fashion
wedding
dress
style
tv mount
Amazon
news
lifestyle
Celebrity News
Kim Kardashian
vichy
neal's yard
aubrey organics
neal's yard remedies
babo botanicals
kiehls store
the body
american auto insurance
auto policy quote
auto quotes online
instant car insurance quote
buy car insurance online
